BCN512 is an orally active inhibitor of the Wnt/beta-catenin signaling pathway that promotes the degradation of beta-catenin by activating GSK-3beta, thereby downregulating associated transcriptional activity. BCN512 inhibits the proliferation of colorectal cancer cells and induces differentiation, making it suitable for use in cancer therapy research.
Molecular Weight:
347.39
Purity:
99.87%
CAS Number:
[346691-54-1]
Formula:
C16H17N3O4S
Target:
Wnt/beta-catenin
T212831
* VAT and and shipping costs not included. Errors and price changes excepted